| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |